Labroots
Home  >  Events  >  SMi’s 2nd Annual Pharmaceutical Microbiology East Coast, Discussing best practice and techniques to tackle microbial control challenges, 10 – 11 April 2019, Battery Wharf Hotel, Boston, USA
SMi’s 2nd Annual Pharmaceutical Microbiology East Coast, Discussing best practice and techniques to tackle microbial control challenges, 10 – 11 April 2019, Battery Wharf Hotel, Boston, USA

SMi’s 2nd Annual Pharmaceutical Microbiology East Coast, Discussing best practice and techniques to tackle microbial control challenges, 10 – 11 April 2019, Battery Wharf Hotel, Boston, USA

Supplier: SMi Group

Description

SPONSORED BY: Associates of Cape Cod, Charles River, bioMérieux, and DuPont
CHAIRED BY: James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society
 
The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation.

Event Hashtag: #SMiPharmaMicroEC

At the 2nd Annual Pharmaceutical Microbiology Conference, you will gain insight into:
•    Design, validation and implementation of a documented and approved disinfectant programme
•    Effective use of environmental monitoring data trending
•    Rapid microbial methods
•    Challenges with endotoxin control
•    Advances in sterility assurance technology
•    Current regulations, challenges and trends in mycoplasma safety testing
•    A "deep dive" case study of atypical, low-level mold contamination

FEATURED SPEAKERS INCLUDE:
•    Cheryl Essex, Head of Microbiological Control for Biologic Drugs, Sanofi
•    Frederic Ayers, Consultant Scientist, Eli Lilly and Company • Christopher Day, Group Leader, ASO Microbiology, Bristol-Myers Squibb
•    Elia Sanchez, QC Microbiology Senior Manager, Genentech
•    Clyde Schultz, Adj Professor, University of Calgary and Director Quality Assurance, Celgene
•    Andrew Bartko, Research Leader, Battelle Memorial Institute

KEY TOPICS FOR 2018 INCLUDE:
•    Regulatory considerations for contamination control
•    Revision of Annex 1 and impact on pharmaceutical microbiology
•    Contamination control strategies and case studies
•    Microbiological methods
•    Regulations of endotoxin detection methods
•    Environmental monitoring
•    Rapid microbial methods
•    Sterility assurance
•    Risk mitigation for mycoplasma and animal sera
 
Plus 2 half day interactive workshops on Friday, April 12th 2019.
Workshop A: Mold Contamination Challenges - Led by: Microrite Inc
Workshop B: Microbiological Control of GMP using Vapour Phase Hydrogen Peroxide bio-Decontamination – Led by: PHSS & Franz Ziel GmbH
 
View the full agenda: www.microbiologyeastcoast.com
 
WHO SHOULD ATTEND
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist
 
EARLY BIRD-RATES
•    BOOK BY 31ST JANUARY AND SAVE £200
•    BOOK BY 28TH FEBRUARY AND SAVE £100

Website:  www.microbiologyeastcoast.com/absave